Collegium Pharmaceutical Inc expected to post a loss of 13 cents a share - Earnings Preview

Collegium Pharmaceutical

02/11/2022 02:11

* Collegium Pharmaceutical Inc  COLL.OQ   COLL.O  is
expected
to show a rise in quarterly revenue when it reports  results on
November 3. 
    * The Stoughton Massachusetts-based  company is expected to
report
 a 57.8% increase in revenue to $124.446 million from $78.84
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Collegium
Pharmaceutical
Inc is for a loss of 13 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $36​, above​ its last closing price
of $18.55. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  1.38        1.42       0.32      Missed  -77.5
 Mar. 31 2022  0.90        0.90       0.44      Missed  -50.9
 Dec. 31 2021  1.06        1.04       -0.51     Missed  -149.2
                                                        ​
 Sep. 30 2021  0.95        0.95       0.22      Missed  -76.9
 ​​Jun.        0.36        0.47       0.27      Missed  -42.8
 30 2021                                                
 Mar. 31 2021  0.30        0.42       0.41      Missed  -2.8​
 Dec. 31 2020  0.28        0.39       0.20      Missed  -48.5
 Sep. 30 2020  0.23        0.41       0.32      Missed  -21.7
 This summary was machine generated November 2 at 02:11 GMT.  All
figures in US dollars  unless otherwise stated